Effects of Niacin Therapy on Lipoprotein Composition and Function

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 25, 2015

Primary Completion Date

April 7, 2019

Study Completion Date

July 23, 2019

Conditions
Cardiovascular Disease
Interventions
DIETARY_SUPPLEMENT

Niacin Extended Release

Subjects will receive a 2 week supply of the dietary supplement Rugby Extended Release Niacin (250 mg/tablet) Niacin and will be instructed to take 2 tablets per day (500 mg/day) for the first seven days and then increase to 4 tablets per day (1000 mg/day) during the following 7 days. Subjects will then be escalated to 2000 mg/day for 14 weeks.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT02322203 - Effects of Niacin Therapy on Lipoprotein Composition and Function | Biotech Hunter | Biotech Hunter